Preparation of sheddable PEG modified miRNA-complexing nanoparticles and its preliminary<i> in vitro</i> and<i> in vivo</i> study

ZENG Ye; ZHOU Zixuan; SUN Xun

doi:10.11665/j.issn.1000-5048.20160612

Journal of China Pharmaceutical University > 2016 > 47(6): 702-707. > DOI: 10.11665/j.issn.1000-5048.20160612

ZENG Ye, ZHOU Zixuan, SUN Xun. Preparation of sheddable PEG modified miRNA-complexing nanoparticles and its preliminary in vitro and in vivo study[J]. Journal of China Pharmaceutical University, 2016, 47(6): 702-707. DOI: 10.11665/j.issn.1000-5048.20160612

Citation:

PDF (2697 KB)

Preparation of sheddable PEG modified miRNA-complexing nanoparticles and its preliminary in vitro and in vivo study

More Information

Graphical Abstract

Abstract

Abstract

This study was aimed to prepare sheddable PEG modified miRNA-complexing nanoparticles and investigate in vitro cellular uptake effect and in vivo distribution profile. The sheddable PEG material was synthesized through condensation. The sheddable PEG modified miRNA-complexing nanoparticles were successfully prepared by electrostatic interaction between gene vector and miRNA, and then ibuprofen was added to deshield PEG layer. The in vitro cellular uptake effect and in vivo distribution profile of nanoparticles were investigated on 4T1 model cells. As a result, the particle size of nanoparticles was 107. 7 nm and Zeta potential was 15. 8 mV. Compared to unsheddable PEG group, the cellular uptake effect by 4T1 tumor cells as well as the concentration on tumor regions was significantly improved in the sheddable PEG group. Results showed that this systen has a great potential application in the field of tumor treatment.
- sheddable PEG,
- gene vector,
- nanoparticles,
- MiR-34a,
- 4T1 cells,
- breast cancer

FullText(HTML)

References (11)

References

[1]	Bartel DP.MicroRNAs:target recognition and regulatory functions[J].Cell,2009,136(2):215-233.
[2]	Ventura A, Jacks T. MicroRNAs and cancer: short RNAs go a long way[J].Cell,2009,136(4):586-591.
[3]	Zhu L,Mahato RI.Targeted delivery of siRNA to hepatocytes and hepatic stellate cells by bioconjugation[J].Bioconjug Chem,2010,21(11):2119-2127.
[4]	Li FY,Zhou JP,Wu XM,et al.Formula optimization and transfection efficiency of polyethyleneimine/DNA complexes[J].J China Pharm Univ(中国药科大学学报),2010,41(1):40-44.
[5]	Dash PR, Read ML, Barrett LB, et al. Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery [J].Gene Ther,1999,6(4):643-650.
[6]	Caplen NJ.Gene therapy progress and prospects.Downregulating gene expression:the impact of RNA interference [J].Gene Ther,2004,11(16):1241-1248.
[7]	Vile RG,Russell SJ,Lemoine NR.Cancer gene therapy:hard lessons and new courses [J].Gene Ther,2000,7(7):2-8.
[8]	Li YH,Zong L,Zhu JB,et al.Formulation optimization of PEGylated cationic liposomes as siRNA delivery system [J].J China Pharm Univ(中国药科大学学报),2011,42(5):412-417.
[9]	Mishra S, Webster P, Davis ME, et al. PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles [J].Eur J Cell Biol,2004,83(3):97-111.
[10]	Pun SH,Bellocq NC,Liu A,et al.Cyclodextrin-modified polyethylenimine polymers for gene delivery [J].Bioconjug Chem,2004,15(4):831-840.
[11]	Larsen KL,Endo T,Ueda H,et al.Inclusion complex formation constants of α-,β-,γ-,δ-,ε-,ζ-,η- and θ-cyclodextrins determined with capillary zone electrophoresis [J].Carbohydr Res,1998,309(309):153-159.

Cited By

Get Citation

PDF

XML

Article views (692) PDF downloads (1087)

Turn off MathJax

Article Contents

Abstract

References

Preparation of sheddable PEG modified miRNA-complexing nanoparticles and its preliminary in vitro and in vivo study

Abstract

References

Catalog

Export File

Citation

Format

Content